Ligand Pharmaceuticals Incorporated Contingent Value Rights (LGNYZ)
Market Open
12 Aug, 14:31
OTC PINK OTC PINK Primary $
0. 06
+0
+9.2593%
$
741.52K Market Cap
- P/E Ratio
- Div Yield
4,973 Volume
0 Eps
$ 0.05
Previous Close Want to track LGNYZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LGNYZ Earnings Reports FAQ
What is the earnings per share (EPS) for LGNYZ?
The current EPS is 0.
What is the company's earnings growth rate?
Ligand Pharmaceuticals Incorporated Contingent Value Rights has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Ligand Pharmaceuticals Incorporated Contingent Value Rights has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ligand Pharmaceuticals Incorporated Contingent Value Rights are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LGNYZ at this time, as Ligand Pharmaceuticals Incorporated Contingent Value Rights has no recent EPS data to calculate it.
